Tuesday, November 3, 2026

Stray Kids Dominates K-Pop: How Their This and That is Changing the Game

Stray Kids secures the top spot in K-pop idols for the second consecutive time in the latest rankings.

Why You Can’t Miss SEVENTEEN’s V8 Concert: A New Era of Live Music Experience

SEVENTEEN's V8 subunit, featuring Dino and Vernon, will host their first concert in Goyang, promising an immersive and energetic experience.

New Feed Additives: Freshwater Microalgae Enhance Broiler Immunity and Gut Bacteria

South Korean research shows freshwater microalgae can enhance intestinal health in broiler chickens, suggesting potential as a feed additive.

Health

How Samsung Medical Center Reduced Waste by 80%: A Game-Changer in ESG Management

Hospitals face pressure to adopt eco-friendly practices due to rising concerns over waste and disposable items impacting the environment.

Q901: The Promising New Hope for Pediatric Brain Tumors – What You Need to Know About This FDA-Approved Therapy

Qurient, the major shareholder of DongKoo Bio&Pharma, received FDA approval for a pediatric brain tumor trial of Q901.

IKS014 vs. Enhertu: Can This New HER2 ADC Drug Revolutionize Breast Cancer Treatment?

IKS014 shows a 50% objective response rate in HER2-positive breast cancer patients previously treated with Enhertu.

IMB-105: The Next Breakthrough in Autoimmune Disease Treatment?

IMBiologics partners with GC Pharma to develop next-generation autoimmune disease treatments.

How MEDTIS is Revolutionizing Remote Healthcare in Asia: Insights from Health On Cloud’s CEO

Trust is essential for Korean medical technology to enter foreign markets, according to Jeon Sang-hoon, CEO of Health On Cloud.
Latest

How GCCL and KBIOHealth’s New Agreement Will Transform Clinical Trials in South Korea

GCCL signs MOU with KBIOHealth to enhance clinical research and drug development, integrating public research with industry expertise.

Digital Health Week 2026: How Daewoong Pharmaceutical is Revolutionizing Healthcare with 8 Innovative Products

Daewoong Pharmaceutical's Digital Health Week 2026 showcased digital healthcare innovations to 39,753 professionals, highlighting real-world applications.

HD Construction Equipment Launches First Safety Certification for Electric Equipment

HD Construction Equipment launches certifications for high-voltage handling and safety management of electric machinery in Korea.

How I’mfacto AI Atlas Revolutionizes Manufacturing Efficiency: Key Insights from AW2026

Hansol PNS showcased its AI-driven manufacturing solutions at AW2026, emphasizing data optimization and process automation.

How Korea’s New Digital Health Device Certification Will Impact Your Wellness Tech in 2026

The Korea AI Healthcare Research Institute gains certification authority for digital health devices, enhancing testing and industry support.

How AI-Powered Wearable Tech is Revolutionizing Epilepsy Monitoring in 2026

SK Biopharmaceuticals and Emory University launch a two-year AI project for seizure detection using EEG data and wearable devices.

Wave Global: Innovative Medical Solutions Unveiled at Wontech’s Seoul Event for Global Expansion

Wontech will host the Wave Global event in Seoul on March 21, marking a strategic push for global expansion and engagement.

Huons BioPharma’s Botulinum Toxin HUTOX Set to Transform the Chinese Market

Huons BioPharma partners with iMaker Technology to supply botulinum toxin, aiming for a strong market presence in China.

Phonak Holds Leadership Seminar, Unveils New Virto Infinio R hearing aid

Phonak's seminar showcased AI hearing tech and the new Virto Infinio R hearing aid, emphasizing hearing health in an aging society.

Celltrion’s Breakthrough: Why Vegzelma and Herzuma Lead in Japan’s Oncology Market

Celltrion's cancer treatments dominate the Japanese market, with Vegzelma and Herzuma capturing significant shares, showcasing strong growth.

How Celltrion Plans to Cut Biologics Development Costs by 25% Amid FDA Regulation Changes

Celltrion is optimistic about enhanced competitiveness due to eased biosimilar regulations by the FDA, expecting significant cost reductions.

Discover the Excellence of Botulax and Revolax at Thailand’s Largest Dermatology Conference

Hugel showcased its HA filler Revolax and botulinum toxin products at Thailand's largest dermatology conference, enhancing medical engagement.

Celltrion’s CT-P55: What Changes to FDA Clinical Trials Mean for Biosimilarity with Cosentyx?

Celltrion has applied to the FDA for changes to its Phase 3 trial of CT-P55, reducing participants to 153 to assess biosimilarity to Cosentyx.

Alteogen Secures U.S. Patent for Keytruda Subcutaneous Injection: What This Means for ALT-B4 and Future Treatments

Alteogen secures a U.S. patent for a subcutaneous Keytruda formulation using ALT-B4, ensuring exclusivity until 2043 and potential $1B in sales.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.